Genfit Adr (GNFT)

Jan 30, 2025

GENFIT annonce un accord de financement non dilutif de partage de redevances (royalty financing) et un plan de réduction de sa dette - GlobeNewswire Inc.

Jan 30, 2025

Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 09, 2024

Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Oct 09, 2024

Sep 29, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN

Sep 29, 2024

Sep 26, 2024

European Equities Traded in the US as American Depositary Receipts Move Higher in Tuesday Trading - MSN

Sep 26, 2024

Sep 21, 2024

European Equities Traded in the US as American Depositary Receipts Decrease Friday - MSN

Sep 21, 2024

Sep 19, 2024

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN

Sep 19, 2024

Sep 13, 2024

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN

Sep 13, 2024

Sep 08, 2024

European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading - MSN

Sep 08, 2024

Sep 06, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN

Sep 06, 2024

Sep 06, 2024

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - MSN

Sep 06, 2024

Aug 30, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Aug 30, 2024

Aug 21, 2024

European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading - MSN

Aug 21, 2024

Jun 10, 2024

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis - Finansavisen

Jun 10, 2024

Nov 20, 2023

European Equities Traded in the US as American Depositary Receipts Start Week Higher - MSN

Nov 20, 2023

Nov 13, 2023

Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine - Ipsen

Nov 13, 2023

Jun 30, 2023

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease - Ipsen

Jun 30, 2023

Dec 18, 2021

Ipsen und GENFIT schließen im Rahmen einer langfristigen globalen Partnerschaft eine exklusive Lizenzvereinbarung für Elafibranor ab, ein Phase-III-Asset, das für die Behandlung von primärer biliärer Cholangitis geprüft wird - Business Wire

Dec 18, 2021

Dec 17, 2021

GENFIT: Ipsen and GENFIT enter into exclusive licensing - GlobeNewswire

Dec 17, 2021

Jun 27, 2019

The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO - Yahoo Finance

Jun 27, 2019

Apr 09, 2019

The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing - Yahoo Finance

Apr 09, 2019